| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |